Kenneth J. Mcgrath Purchases 64,000 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. (NASDAQ:OSUR) CFO Kenneth J. Mcgrath acquired 64,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The shares were bought at an average cost of $3.15 per share, for a total transaction of $201,600.00. Following the purchase, the chief financial officer now owns 371,013 shares of the company’s stock, valued at approximately $1,168,690.95. The trade was a 20.85 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

OraSure Technologies Stock Up 11.2 %

OSUR opened at $3.48 on Friday. The firm has a market cap of $259.59 million, a P/E ratio of 23.20 and a beta of 0.05. OraSure Technologies, Inc. has a 52 week low of $2.68 and a 52 week high of $7.81. The business’s fifty day simple moving average is $3.78 and its 200 day simple moving average is $4.00.

Institutional Trading of OraSure Technologies

A number of hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD boosted its stake in OraSure Technologies by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 76,932 shares of the medical instruments supplier’s stock worth $278,000 after buying an additional 3,828 shares during the last quarter. Invesco Ltd. boosted its stake in OraSure Technologies by 3.4% in the 4th quarter. Invesco Ltd. now owns 127,526 shares of the medical instruments supplier’s stock worth $460,000 after buying an additional 4,240 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in OraSure Technologies by 202.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 5,234 shares during the last quarter. Legal & General Group Plc boosted its stake in OraSure Technologies by 32.3% in the 4th quarter. Legal & General Group Plc now owns 23,626 shares of the medical instruments supplier’s stock worth $85,000 after buying an additional 5,770 shares during the last quarter. Finally, Orion Portfolio Solutions LLC boosted its stake in OraSure Technologies by 10.7% in the 4th quarter. Orion Portfolio Solutions LLC now owns 61,170 shares of the medical instruments supplier’s stock worth $221,000 after buying an additional 5,929 shares during the last quarter. 93.50% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, February 22nd.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.